FinTechFunding

Curebase: Raises $40M in Series B Funding

Curebase Raises $40M in Series B Funding

  • Curebase, a San Francisco, CA-based technology-driven clinical trial startup, raised $40m in Series B funding
  • The round was led by Industry Ventures, with participation from Acrew Capital, World Innovation Lab and Positive Sum, Gaingels, GGV Capital, Bold Capital and Xfund
  • The round also included a strategic investment by global biopharmaceutical company Gilead Sciences
  • The company, which has raised a total of $59m, intends to use the funds to continue development of its solutions
  • The company provides decentralized clinical trials (DCTs) and patient-centric clinical trial software
  • The company has now run over 50 studies to date, with 300-400% growth year over year
Previous article
Lumos: Raises Over $30M in Funding
Next article
Valia Ventures: Closes Fund II, at $50M
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...
FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...